S. Chen and G. Parmigiani, Penetrance, Journal of Clinical Oncology, vol.25, issue.11, pp.1329-1362, 2007.
DOI : 10.1200/JCO.2006.09.1066

V. Bonadona, B. Bonaïti, S. Olschwang, S. Grandjouan, L. Huiart et al., Cancer Risks Associated With Germline Mutations in <emph type="ital">MLH1</emph>, <emph type="ital">MSH2</emph>, and <emph type="ital">MSH6</emph> Genes in Lynch Syndrome, JAMA, vol.305, issue.22, pp.2304-2314, 2011.
DOI : 10.1001/jama.2011.743

F. Eisinger, B. Bressac, D. Castaigne, P. Cottu, J. Lansac et al., Identification et prise en charge des prédispositions héréditaires aux cancers du sein et de l'ovaire (mise à jour, Bull Cancer, vol.91, pp.219-256, 2004.

M. Robson and K. Offit, Management of an Inherited Predisposition to Breast Cancer, New England Journal of Medicine, vol.357, issue.2, pp.154-62, 2007.
DOI : 10.1056/NEJMcp071286

S. Olschwang, C. Bonaiti, J. Feingold, T. Frebourg, S. Grandjouan et al., Identification et prise en charge du syndrome HNPCC (Hereditary NonPolyposis Colon Cancer), prédisposition héréditaire aux cancers du côlon, du rectum et de l'utérus, Bull Cancer, vol.91, pp.303-318, 2004.

N. Lindor, G. Petersen, D. Hadley, A. Kinney, S. Miesfeldt et al., Recommendations for the Care of Individuals With an Inherited Predisposition to Lynch Syndrome, JAMA, vol.296, issue.12, pp.1507-1524, 2006.
DOI : 10.1001/jama.296.12.1507

A. Antoniou and D. Easton, Risk prediction models for familial breast cancer, Future Oncology, vol.2, issue.2, pp.257-74, 2006.
DOI : 10.2217/14796694.2.2.257

G. Parmigiani, D. Berry, and O. Aguilar, Determining Carrier Probabilities for Breast Cancer???Susceptibility Genes BRCA1 and BRCA2, The American Journal of Human Genetics, vol.62, issue.1, pp.145-58, 1998.
DOI : 10.1086/301670

A. Antoniou, P. Pharoah, P. Smith, and D. Easton, The BOADICEA model of genetic susceptibility to breast and ovarian cancer, British Journal of Cancer, vol.88, pp.1580-90, 2004.
DOI : 10.1038/sj.bjc.6602175

J. Tyrer, S. Duffy, and J. Cuzick, A breast cancer prediction model incorporating familial and personal risk factors, Statistics in Medicine, vol.6, issue.7, pp.111-1130, 2004.
DOI : 10.1002/sim.1668

D. Evans, D. Eccles, N. Rahman, K. Young, M. Bulman et al., A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO, Journal of Medical Genetics, vol.41, issue.6, pp.474-80, 2004.
DOI : 10.1136/jmg.2003.017996

D. Evans, F. Lalloo, A. Wallace, and N. Rahman, Update on the Manchester Scoring System for BRCA1 and BRCA2 testing, Journal of Medical Genetics, vol.42, issue.7, p.39, 2005.
DOI : 10.1136/jmg.2005.031989

D. Stoppa-lyonnet, C. Noguès, H. Sobol, and F. Eisinger, Consultations de génétique et prédisposition aux cancers du sein, Risques héréditaires de cancers du sein et de l'ovaire: Quelle prise en charge? Paris: Inserm, 1998.

B. Bonaïti, F. Alarcon, and V. Bonadona, Nouveau système de score pour le diagnostic des prédispositions aux cancers du sein et de l'ovaire associées à BRCA1, Bull Cancer, vol.98, issue.2, pp.779-95, 2011.

D. Evans, F. Lalloo, A. Cramer, E. Jones, F. Knox et al., Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing, Journal of Medical Genetics, vol.46, issue.12, pp.811-828, 2009.
DOI : 10.1136/jmg.2009.067850
URL : https://hal.archives-ouvertes.fr/hal-00552701

S. Olschwang, Germline mutation and genome instability, European Journal of Cancer Prevention, vol.8, issue.1, pp.33-40, 1999.
DOI : 10.1097/00008469-199912001-00006

H. Risch, J. Mclaughlin, D. Cole, B. Rosen, L. Bradley et al., Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin-Cohort Study in Ontario, Canada, JNCI Journal of the National Cancer Institute, vol.98, issue.23, pp.1694-706, 2006.
DOI : 10.1093/jnci/djj465

C. Asperen, R. Brohet, E. Meijers-heijboer, N. Hoogerbrugge, S. Verhoef et al., Cancer risks in BRCA2 families: estimates for sites other than breast and ovary, Journal of Medical Genetics, vol.42, issue.9, pp.711-730, 2005.
DOI : 10.1136/jmg.2004.028829

Y. Tai, S. Domchek, G. Parmigiani, and S. Chen, Breast Cancer Risk Among Male BRCA1 and BRCA2 Mutation Carriers, JNCI Journal of the National Cancer Institute, vol.99, issue.23, pp.1811-1825, 2007.
DOI : 10.1093/jnci/djm203
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2267289

R. Angelis, R. Capocaccia, T. Hakulinen, B. Soderman, and A. Verdecchia, Mixture models for cancer survival analysis: application to population-based data with covariates, Statistics in Medicine, vol.101, issue.4, pp.441-54, 1999.
DOI : 10.1002/(SICI)1097-0258(19990228)18:4<441::AID-SIM23>3.0.CO;2-M

B. Bonaiti, V. Bonadona, H. Perdry, N. Andrieu, and C. Bonaiti-pellie, Estimating penetrance from multiple case families with predisposing mutations: extension of the ???genotype-restricted likelihood??? (GRL) method, European Journal of Human Genetics, vol.33, issue.2, pp.173-182, 2011.
DOI : 10.1038/ejhg.2010.158
URL : https://hal.archives-ouvertes.fr/hal-00583530

A. Belot, P. Grosclaude, N. Bossard, E. Jougla, E. Benhamou et al., Cancer incidence and mortality in France over the period 1980???2005, Revue d'??pid??miologie et de Sant?? Publique, vol.56, issue.3, pp.159-75, 1980.
DOI : 10.1016/j.respe.2008.03.117
URL : https://hal.archives-ouvertes.fr/hal-00538673

D. Atchley, C. Albarracin, A. Lopez, V. Valero, C. Amos et al., -Negative Breast Cancer, Journal of Clinical Oncology, vol.26, issue.26, pp.4282-4290, 2008.
DOI : 10.1200/JCO.2008.16.6231
URL : https://hal.archives-ouvertes.fr/hal-00894139

B. Haffty, Q. Yang, M. Reiss, T. Kearney, S. Higgins et al., Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer, Journal of Clinical Oncology, vol.24, issue.36, pp.5652-5659, 2006.
DOI : 10.1200/JCO.2006.06.5664

A. Antoniou, P. Pharoah, G. Mcmullan, N. Day, M. Stratton et al., A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes, British Journal of Cancer, vol.60, issue.1, pp.76-83, 2002.
DOI : 10.1086/318181

I. Brozek, K. Ochman, J. Debniak, L. Morzuch, M. Ratajska et al., High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland, Gynecologic Oncology, vol.108, issue.2, pp.433-440, 2008.
DOI : 10.1016/j.ygyno.2007.09.035

C. Jacobi, Y. Van-ierland, C. Van-asperen, E. Hallensleben, P. Devilee et al., Prediction of BRCA1/2 mutation status in patients with ovarian cancer from a hospital-based cohort, Genetics in Medicine, vol.351, issue.3, pp.173-182, 2007.
DOI : 10.1097/GIM.0b013e318032e4ab

H. Risch, J. Mclaughlin, D. Cole, B. Rosen, L. Bradley et al., Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer, The American Journal of Human Genetics, vol.68, issue.3, pp.700-710, 2001.
DOI : 10.1086/318787

F. Alarcon, C. Bourgain, M. Gauthier-villars, V. Plante-bordeneuve, D. Stoppa-lyonnet et al., PEL: an unbiased method for estimating age-dependent genetic disease risk from pedigree data unselected for family history, Genetic Epidemiology, vol.9, issue.5, pp.379-85, 2009.
DOI : 10.1002/gepi.20390
URL : https://hal.archives-ouvertes.fr/inserm-00358140

S. Pennec, Four-Generation families in France, Popul Eng Sel, vol.9, pp.75-101, 1997.

L. Toulemon, How many children and how many siblings in France in the last century?, Popul Societies, vol.373, pp.1-4, 2001.

R. Elston and J. Stewart, A General Model for the Genetic Analysis of Pedigree Data, Human Heredity, vol.21, issue.6, pp.523-565, 1971.
DOI : 10.1159/000152448

C. Bonaiti-pellie, N. Andrieu, P. Arveux, V. Bonadona, B. Buecher et al., Oncogénétique: estimation des besoins de la populations en France pour les 10 ans à venir, Bull Cancer, vol.96, pp.875-900, 2009.

A. Antoniou, R. Hardy, L. Walker, D. Evans, A. Shenton et al., Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics, Journal of Medical Genetics, vol.45, issue.7, pp.425-456, 2008.
DOI : 10.1136/jmg.2007.056556

J. Cui and J. Hopper, Why are the majority of hereditary cases of early-onset breast cancer sporadic? A simulation study, Cancer Epidemiol Biomarkers Prev, vol.9, pp.805-817, 2000.